GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand ...

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

A New York doctor who treated HIV and AIDS patients sued Gilead for violating the False Claims Act with payments to doctors ...

In Zambia, truck drivers and sex workers have high rates of being HIV positive —- and are at high risk of contracting the ...

An ambitious plan to stop the global threat of AIDS has been derailed. But many are hopeful that progress can be salvaged.

The US administration should clear up the confusion over the future of a widely admired AIDS fund and push for Congress to ...

Dolutegravir is recommended by the World Health Organization (WHO) for infants, children and adults and is the preferred HIV ...

Cuts to sexual health clinics could make eliminating new HIV cases in England by 2030 “impossible”, politicians have warned.

A safety analysis of mRNA vaccination in a phase 1, randomized, open-label clinical trial evaluated the safety and ...

An HIV patient in Laredo is sharing his advice with others living with the disease to raise awareness and highlight available ...

The Uganda AIDS Commission (UAC) has reported a continued decline in new HIV infections, though the country still falls short ...

The company paid to settle allegations of paying kickbacks to doctors in exchange for prescribing several of its HIV medicines.